{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:20:02Z","timestamp":1794543602323,"version":"4.9.1"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.clineuro.2025.108719","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:20:28Z","timestamp":1736209228000},"page":"108719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["The overlap of diabetic and inflammatory neuropathies: Epidemiology, possible mechanisms, and treatment implications"],"prefix":"10.1016","volume":"249","author":[{"given":"Yusuf A.","family":"Rajabally","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Gi","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clineuro.2025.108719_bib1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00400697","article-title":"A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population","volume":"36","author":"Young","year":"1993","journal-title":"Diabetologia"},{"issue":"9131","key":"10.1016\/j.clineuro.2025.108719_bib2","first-page":"837","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"UKPDS","year":"1998","journal-title":"UK Prospect. Diabetes Study (UKPDS) Group. Lancet"},{"issue":"6","key":"10.1016\/j.clineuro.2025.108719_bib3","first-page":"359","article-title":"Reproducibility of different nerve conduction velocity measurements in healthy test subjects and patients suffering from diabetic polyneuropathy","volume":"37","author":"Husstedt","year":"1997","journal-title":"Electro Clin. Neurophysiol."},{"issue":"2","key":"10.1016\/j.clineuro.2025.108719_bib4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mus.21661","article-title":"Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trial","volume":"42","author":"Dyck","year":"2010","journal-title":"Muscle nerve"},{"issue":"8","key":"10.1016\/j.clineuro.2025.108719_bib5","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1212\/WNL.53.8.1634","article-title":"Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies","volume":"53","author":"Herrmann","year":"1999","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.clineuro.2025.108719_bib6","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/ene.15129","article-title":"Corneal nerve loss is related to the severity of painful diabetic neuropathy","volume":"29","author":"Kalteniece","year":"2022","journal-title":"Eur. J. Neurol."},{"issue":"10","key":"10.1016\/j.clineuro.2025.108719_bib7","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1093\/brain\/awab330","article-title":"Progression and regression of nerve fibre pathology and dysfunction early in diabetes over 5 years","volume":"144","author":"Ziegler","year":"2021","journal-title":"Brain: a J. Neurol."},{"issue":"10","key":"10.1016\/j.clineuro.2025.108719_bib8","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1093\/brain\/awab355","article-title":"Distal symmetric polyneuropathy in diabetes: a progressive disorder?","volume":"144","author":"Jensen","year":"2021","journal-title":"Brain: a J. Neurol."},{"key":"10.1016\/j.clineuro.2025.108719_bib9","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-016-8375-x","article-title":"The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension","author":"Gibbons","year":"2017","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.clineuro.2025.108719_bib10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s40200-020-00493-5","article-title":"Classification of functionality of people with diabetic peripheral neuropathy based on international classification of functioning, disability and health Core set (ICF-CS) of diabetes mellitus","volume":"19","author":"Fatma","year":"2020","journal-title":"J. Diabetes Metab. Disord."},{"issue":"11","key":"10.1016\/j.clineuro.2025.108719_bib11","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1111\/ene.14959","article-title":"European academy of neurology\/peripheral nerve society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force-second revision","volume":"28","author":"Van den Bergh","year":"2021","journal-title":"Eur. J. Neurol."},{"issue":"6 Pt 2","key":"10.1016\/j.clineuro.2025.108719_bib12","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1016\/j.lpm.2013.01.056","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy","volume":"42","author":"Van den Bergh","year":"2013","journal-title":"Presse Med. (Paris, Fr.: 1983)"},{"issue":"Pt 6","key":"10.1016\/j.clineuro.2025.108719_bib13","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/brain\/124.6.1197","article-title":"Norell JE. Non-diabetic lumbosacral radiculoplexus neuropathy: natural history, outcome and comparison with the diabetic variety","volume":"124","author":"Dyck","year":"2001","journal-title":"Brain: a J. Neurol."},{"issue":"Pt 10","key":"10.1016\/j.clineuro.2025.108719_bib14","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1093\/brain\/aws244","article-title":"Diabetic cervical radiculoplexus neuropathy: a distinct syndrome expanding the spectrum of diabetic radiculoplexus neuropathies","volume":"135","author":"Massie","year":"2012","journal-title":"Brain: a J. Neurol."},{"issue":"12","key":"10.1016\/j.clineuro.2025.108719_bib15","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1111\/ene.16073","article-title":"European Academy of Neurology\/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barr\u00e9 syndrome","volume":"30","author":"van Doorn","year":"2023","journal-title":"Eur. J. Neurol."},{"issue":"10045","key":"10.1016\/j.clineuro.2025.108719_bib16","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.clineuro.2025.108719_bib17","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s00125-004-1663-5","article-title":"Sural nerve pathology in diabetic patients with minimal but progressive neuropathy","volume":"48","author":"Malik","year":"2005","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.clineuro.2025.108719_bib18","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.2337\/diabetes.52.10.2615","article-title":"Endoneurial capillary abnormalities presage deterioration of glucose tolerance and accompany peripheral neuropathy in man","volume":"52","author":"Thrainsdottir","year":"2003","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.clineuro.2025.108719_bib19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1212\/WNL.37.1.20","article-title":"Abnormalities of endoneurial microvessels and sural nerve pathology in diabetic neuropathy","volume":"37","author":"Yasuda","year":"1987","journal-title":"Neurology"},{"issue":"Pt 12","key":"10.1016\/j.clineuro.2025.108719_bib20","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1093\/brain\/124.12.2427","article-title":"Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy","volume":"124","author":"Bosboom","year":"2001","journal-title":"Brain: a J. Neurol."},{"issue":"5","key":"10.1016\/j.clineuro.2025.108719_bib21","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/mus.24930","article-title":"Endoneurial edema in sural nerve may indicate recent onset inflammatory neuropathy","volume":"53","author":"Uceyler","year":"2016","journal-title":"Muscle Nerve"},{"issue":"11","key":"10.1016\/j.clineuro.2025.108719_bib22","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1212\/01.WNL.0000096174.86850.7F","article-title":"Diagnostic value of sural nerve matrix metalloproteinase-9 in diabetic patients with CIDP","volume":"61","author":"Jann","year":"2003","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.clineuro.2025.108719_bib23","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/jnen\/59.6.525","article-title":"Microvasculitis in non-diabetic lumbosacral radiculoplexus neuropathy (LSRPN): similarity to the diabetic variety (DLSRPN)","volume":"59","author":"Dyck","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"Pt 2","key":"10.1016\/j.clineuro.2025.108719_bib24","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/brain\/awg029","article-title":"Inflammatory vasculopathy in multifocal diabetic neuropathy","volume":"126","author":"Said","year":"2003","journal-title":"Brain: A J. Neurol."},{"issue":"5","key":"10.1016\/j.clineuro.2025.108719_bib25","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/glia.23755","article-title":"Disrupting insulin signaling in Schwann cells impairs myelination and induces a sensory neuropathy","volume":"68","author":"Hackett","year":"2020","journal-title":"Glia"},{"issue":"7","key":"10.1016\/j.clineuro.2025.108719_bib26","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41574-021-00496-z","article-title":"Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy","volume":"17","author":"Sloan","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"issue":"4","key":"10.1016\/j.clineuro.2025.108719_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14477","article-title":"How inflammation dictates diabetic peripheral neuropathy: An enlightening review","volume":"30","author":"Cheng","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"4","key":"10.1016\/j.clineuro.2025.108719_bib28","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3988\/jcn.2014.10.4.334","article-title":"Up-regulation of the receptor for advanced glycation end products in the skin biopsy specimens of patients with severe diabetic neuropathy","volume":"10","author":"Park","year":"2014","journal-title":"J. Clin. Neurol."},{"issue":"1","key":"10.1016\/j.clineuro.2025.108719_bib29","article-title":"Serum CXCL13 reflects local B-cell mediated inflammatory demyelinating peripheral neuropathy","volume":"9","author":"Kim","year":"2019","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.clineuro.2025.108719_bib30","doi-asserted-by":"crossref","first-page":"8753","DOI":"10.4049\/jimmunol.181.12.8753","article-title":"Targeting of myelin protein zero in a spontaneous autoimmune polyneuropathy","volume":"181","author":"Kim","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.clineuro.2025.108719_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/jns.12622","article-title":"Cytokines and chemokines in patients with chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: A systematic review","author":"Cutell\u00e8","year":"2024","journal-title":"J. Peripher. Nerv. Syst.: JPNS"},{"key":"10.1016\/j.clineuro.2025.108719_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106865","article-title":"Bavachinin inhibits cholesterol synthesis enzyme FDFT1 expression via AKT\/mTOR\/SREBP-2 pathway","volume":"88","author":"Dong","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.clineuro.2025.108719_bib33","doi-asserted-by":"crossref","DOI":"10.2337\/dc23-2208","article-title":"Longitudinal change in serum neurofilament light chain in type 2 diabetes and early diabetic polyneuropathy: ADDITION-Denmark","author":"M\u00e4\u00e4tt\u00e4","year":"2024","journal-title":"Diabetes care"},{"issue":"4","key":"10.1016\/j.clineuro.2025.108719_bib34","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.immuni.2024.03.002","article-title":"DAMPs and DAMP-sensing receptors in inflammation and diseases","volume":"57","author":"Ma","year":"2024","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.clineuro.2025.108719_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/cells11121919","article-title":"The fatal circle of NETs and NET-associated DAMPs contributing to organ dysfunction","volume":"11","author":"Block","year":"2022","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.clineuro.2025.108719_bib36","article-title":"CD40-mediated HIF-1alpha expression underlying microangiopathy in diabetic nerve pathology","volume":"11","author":"Kan","year":"2018","journal-title":"Dis. Model Mech."},{"issue":"1","key":"10.1016\/j.clineuro.2025.108719_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010062","article-title":"Blood-nerve barrier (BNB) pathology in diabetic peripheral neuropathy and in vitro human BNB model","volume":"22","author":"Takeshita","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.clineuro.2025.108719_bib38","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00109-021-02091-1","article-title":"Selective blood-nerve barrier leakiness with claudin-1 and vessel-associated macrophage loss in diabetic polyneuropathy","volume":"99","author":"Ben-Kraiem","year":"2021","journal-title":"J. Mol. Med (Berl.)"},{"issue":"3","key":"10.1016\/j.clineuro.2025.108719_bib39","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/jns.12502","article-title":"Epidemiology of chronic inflammatory demyelinating polyradiculoneuropathy in the Netherlands","volume":"27","author":"Broers","year":"2022","journal-title":"J. Peripher. Nerv. Syst.: JPNS"},{"issue":"4","key":"10.1016\/j.clineuro.2025.108719_bib40","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/mus.21206","article-title":"Epidemiologic variability of chronic inflammatory demyelinating polyneuropathy with different diagnostic criteria: study of a UK population","volume":"39","author":"Rajabally","year":"2009","journal-title":"Muscle nerve"},{"issue":"1-2","key":"10.1016\/j.clineuro.2025.108719_bib41","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/BF00687968","article-title":"Relapsing inflammatory demyelinating polyneuropathy in a diabetic patient","volume":"71","author":"Vital","year":"1986","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/j.clineuro.2025.108719_bib42","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/archneur.59.5.751","article-title":"Diabetic demyelinating polyneuropathy responsive to intravenous immunoglobulin therapy","volume":"59","author":"Sharma","year":"2002","journal-title":"Arch. Neurol."},{"issue":"6","key":"10.1016\/j.clineuro.2025.108719_bib43","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1468-1331.2009.02598.x","article-title":"Cocito D. Comorbidity between CIDP and diabetes mellitus: only a matter of chance?","volume":"16","author":"Chio","year":"2009","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.clineuro.2025.108719_bib44","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1212\/WNL.0b013e3181aaea47","article-title":"Incidence and prevalence of CIDP and the association of diabetes mellitus","volume":"73","author":"Laughlin","year":"2009","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.clineuro.2025.108719_bib45","first-page":"1401","article-title":"The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy","volume":"30","author":"Bril","year":"2016","journal-title":"J. Diabetes\u00a0Complicat."},{"issue":"6","key":"10.1016\/j.clineuro.2025.108719_bib46","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/WNL.0000000000001833","article-title":"CIDP diagnostic pitfalls and perception of treatment benefit","volume":"85","author":"Allen","year":"2015","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.clineuro.2025.108719_bib47","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/mus.25997","article-title":"Electrodiagnostic errors contribute to chronic inflammatory demyelinating polyneuropathy misdiagnosis","volume":"57","author":"Allen","year":"2018","journal-title":"Muscle Nerve"},{"issue":"10","key":"10.1016\/j.clineuro.2025.108719_bib48","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/jnnp-2020-323615","article-title":"Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy","volume":"91","author":"Doneddu","year":"2020","journal-title":"J. Neurol.\u00a0Neurosurg.\u00a0Psychiatry"},{"issue":"10","key":"10.1016\/j.clineuro.2025.108719_bib49","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1136\/jnnp-2020-322971","article-title":"Chronic inflammatory demyelinating polyneuropathy associated with diabetes: a European multicentre comparative reappraisal","volume":"91","author":"Rajabally","year":"2020","journal-title":"J. Neurol.\u00a0Neurosurg.\u00a0Psychiatry"},{"issue":"10","key":"10.1016\/j.clineuro.2025.108719_bib50","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1136\/jnnp-2020-324399","article-title":"Chronic inflammatory demyelinating polyneuropathy and diabetes","volume":"91","author":"Kuwabara","year":"2020","journal-title":"J. Neurol.\u00a0Neurosurg.\u00a0Psychiatry"},{"issue":"4","key":"10.1016\/j.clineuro.2025.108719_bib51","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1212\/WNL.43.4.817","article-title":"The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the rochester diabetic neuropathy study","volume":"43","author":"Dyck","year":"1993","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.clineuro.2025.108719_bib52","doi-asserted-by":"crossref","first-page":"e1188","DOI":"10.1212\/WNL.0000000000007020","article-title":"Lumbosacral radiculoplexus neuropathy: Incidence and the association with diabetes mellitus","volume":"92","author":"Ng","year":"2019","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.clineuro.2025.108719_bib53","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology"},{"issue":"10","key":"10.1016\/j.clineuro.2025.108719_bib54","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1111\/ene.15955","article-title":"Hospital-diagnosed morbidities and recent surgery as risk factors for developing Guillain-Barr\u00e9 syndrome","volume":"30","author":"Levison","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.clineuro.2025.108719_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.875714","article-title":"Influence of hyperglycaemia and CRP on the need for mechanical ventilation in guillain-barr\u00e9 syndrome","volume":"13","author":"\u0160t\u011btk\u00e1\u0159ov\u00e1","year":"2022","journal-title":"Front Neurol."},{"issue":"2","key":"10.1016\/j.clineuro.2025.108719_bib56","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/jns.12206","article-title":"Diabetes mellitus may affect short-term outcome of Guillain-Barr\u00e9 syndrome","volume":"22","author":"Peric","year":"2017","journal-title":"J. Peripher. Nerv. Syst.: JPNS"},{"issue":"3","key":"10.1016\/j.clineuro.2025.108719_bib57","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/ene.12885","article-title":"Diabetes mellitus exacerbates the clinical and electrophysiological features of Guillain-Barr\u00e9 syndrome","volume":"23","author":"Bae","year":"2016","journal-title":"Eur. J. Neurol."},{"issue":"9","key":"10.1016\/j.clineuro.2025.108719_bib58","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrneurol.2017.84","article-title":"Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications","volume":"13","author":"Querol","year":"2017","journal-title":"Nat. Rev. Neurol."},{"issue":"12","key":"10.1016\/j.clineuro.2025.108719_bib59","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1007\/s00415-020-10041-z","article-title":"Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera","volume":"267","author":"Delmont","year":"2020","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.clineuro.2025.108719_bib60","article-title":"Diabetes mellitus is a possible risk factor for nodo-paranodopathy with antiparanodal autoantibodies","volume":"9","author":"Appeltshauser","year":"2022","journal-title":"Neurol. (R. ) Neuroimmunol. Neuroinflamm."},{"issue":"3","key":"10.1016\/j.clineuro.2025.108719_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0281156","article-title":"Contactin-1 links autoimmune neuropathy and membranous glomerulonephritis","volume":"18","author":"Fehmi","year":"2023","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.clineuro.2025.108719_bib62","article-title":"Antiparanodal antibodies and IgG subclasses in acute autoimmune neuropathy","volume":"7","author":"Appeltshauser","year":"2020","journal-title":"Neurol. (R.) Neuroimmunol. Neuroinflamm."},{"issue":"12","key":"10.1016\/j.clineuro.2025.108719_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2024.108883","article-title":"Prevalence and clinical implications of diabetes mellitus in autoimmune nodopathies: a systematic review","volume":"38","author":"Tentolouris","year":"2024","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.clineuro.2025.108719_bib64","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/B978-0-444-52902-2.00026-6","article-title":"Vasculitic neuropathy","volume":"115","author":"Vrancken","year":"2013","journal-title":"Handb. Clin. Neurol."},{"issue":"1","key":"10.1016\/j.clineuro.2025.108719_bib65","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/mus.24088","article-title":"Comparison of sensitivity and specificity among 15 criteria for chronic inflammatory demyelinating polyneuropathy","volume":"50","author":"Breiner","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clineuro.2025.108719_bib66","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2022-329633","article-title":"Application of the 2021 EAN\/PNS criteria for chronic inflammatory demyelinating polyneuropathy","author":"Rajabally","year":"2022","journal-title":"J. Neurol., Neurosurg., Psychiatry"},{"key":"10.1016\/j.clineuro.2025.108719_bib67","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2022-329357","article-title":"Comparison of the diagnostic accuracy of the 2021 EAN\/PNS and 2010 EFNS\/PNS diagnostic criteria for chronic inflammatory demyelinating polyradiculoneuropathy","author":"Doneddu","year":"2022","journal-title":"J. Neurol.\u00a0Neurosurg.\u00a0Psychiatry"},{"issue":"3","key":"10.1016\/j.clineuro.2025.108719_bib68","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","volume":"17","author":"Van den Bergh","year":"2010","journal-title":"Eur. J. Neurol."},{"issue":"12","key":"10.1016\/j.clineuro.2025.108719_bib69","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1136\/jnnp.2009.179358","article-title":"Validity of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy: a multicentre European study","volume":"80","author":"Rajabally","year":"2009","journal-title":"J. Neurol., Neurosurg., Psychiatry"},{"issue":"2","key":"10.1016\/j.clineuro.2025.108719_bib70","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1468-1331.2010.03138.x","article-title":"Distribution, clinical correlates and significance of axonal loss and demyelination in chronic inflammatory demyelinating polyneuropathy","volume":"18","author":"Rajabally","year":"2011","journal-title":"Eur. J. Neurol."},{"issue":"6","key":"10.1016\/j.clineuro.2025.108719_bib71","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/brb3.177","article-title":"Comparison of diabetes patients with \"demyelinating\" diabetic sensorimotor polyneuropathy to those diagnosed with CIDP","volume":"3","author":"Dunnigan","year":"2013","journal-title":"Brain Behav."},{"issue":"11","key":"10.1016\/j.clineuro.2025.108719_bib72","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.2337\/dc13-0746","article-title":"Conduction slowing in diabetic sensorimotor polyneuropathy","volume":"36","author":"Dunnigan","year":"2013","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.clineuro.2025.108719_bib73","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000144083","article-title":"Elevation of cerebrospinal fluid protein in patients with diabetes mellitus is associated with duration of diabetes","volume":"60","author":"Kobessho","year":"2008","journal-title":"Eur. Neurol."},{"issue":"6","key":"10.1016\/j.clineuro.2025.108719_bib74","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/ana.24524","article-title":"Magnetic resonance neurography detects diabetic neuropathy early and with proximal predominance","volume":"78","author":"Pham","year":"2015","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.clineuro.2025.108719_bib75","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/1932296814559303","article-title":"Magnetic resonance imaging may be used for early evaluation of diabetic peripheral polyneuropathy","volume":"9","author":"Vaeggemose","year":"2015","journal-title":"J. Diabetes Sci. Technol."},{"issue":"3","key":"10.1016\/j.clineuro.2025.108719_bib76","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jdiacomp.2015.12.008","article-title":"Sonographic features of peripheral nerves at multiple sites in patients with diabetic polyneuropathy","volume":"30","author":"Kang","year":"2016","journal-title":"J. Diabetes Complicat."},{"issue":"8","key":"10.1016\/j.clineuro.2025.108719_bib77","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1212\/WNL.0000000000001291","article-title":"Peripheral nerve ultrasound changes in CIDP and correlations with nerve conduction velocity","volume":"84","author":"Di Pasquale","year":"2015","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.clineuro.2025.108719_bib78","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/mus.10348","article-title":"Diagnostic value of nerve biopsy for atypical chronic inflammatory demyelinating polyneuropathy: evaluation of eight cases","volume":"27","author":"Vallat","year":"2003","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.clineuro.2025.108719_bib79","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/mus.10080","article-title":"Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: new insights into pathophysiology and treatment","volume":"25","author":"Dyck","year":"2002","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.clineuro.2025.108719_bib80","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/mus.21199","article-title":"Lewis-sumner syndrome of pure upper-limb onset: diagnostic, prognostic, and therapeutic features","volume":"39","author":"Rajabally","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clineuro.2025.108719_bib81","doi-asserted-by":"crossref","DOI":"10.1111\/jns.12569","article-title":"Autoimmune nodo-paranodopathies 10years later: clinical features, pathophysiology and treatment","volume":"28","author":"Uncini","year":"2023","journal-title":"J. Peripher. Nerv. Syst.: JPNS"},{"issue":"1","key":"10.1016\/j.clineuro.2025.108719_bib82","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(13)70236-9","article-title":"Vasculitic neuropathies","volume":"13","author":"Gwathmey","year":"2014","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.clineuro.2025.108719_bib83","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1007\/s00415-020-10287-7","article-title":"Underdiagnosis and diagnostic delay in chronic inflammatory demyelinating polyneuropathy","volume":"268","author":"Chaudhary","year":"2021","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.clineuro.2025.108719_bib84","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ana.1088","article-title":"Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"50","author":"Hughes","year":"2001","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.clineuro.2025.108719_bib85","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/jnnp.2005.081547","article-title":"A modified peripheral neuropathy scale: the overall neuropathy limitations scale","volume":"77","author":"Graham","year":"2006","journal-title":"J. Neurol., Neurosurg.\u00a0Psychiatry"},{"issue":"4","key":"10.1016\/j.clineuro.2025.108719_bib86","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1212\/WNL.0b013e318208824b","article-title":"Rasch-built overall disability scale (R-ODS) for immune-mediated peripheral neuropathies","volume":"76","author":"van Nes","year":"2011","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.clineuro.2025.108719_bib87","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1468-1331.2012.03851.x","article-title":"Vigorimeter grip strength in CIDP: a responsive tool that rapidly measures the effect of IVIG--the ICE study","volume":"20","author":"Vanhoutte","year":"2013","journal-title":"Eur. J. Neurol."},{"issue":"1-2","key":"10.1016\/j.clineuro.2025.108719_bib88","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jns.2012.11.010","article-title":"Jamar hand-held grip dynamometry in chronic inflammatory demyelinating polyneuropathy","volume":"325","author":"Rajabally","year":"2013","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.clineuro.2025.108719_bib89","article-title":"Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews","author":"Oaklander","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.clineuro.2025.108719_bib90","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00415-018-9157-4","article-title":"Clinical and economic comparison of an individualised immunoglobulin protocol vs. standard dosing for chronic inflammatory demyelinating polyneuropathy","volume":"266","author":"Rajabally","year":"2019","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.clineuro.2025.108719_bib91","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mus.27046","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy-Diagnostic pitfalls and treatment approach","volume":"63","author":"Stino","year":"2021","journal-title":"Muscle Nerve"},{"issue":"4(Special","key":"10.1016\/j.clineuro.2025.108719_bib92","first-page":"1361","article-title":"Efficacy of azathioprine and methotrexate in patients with chronic inflammatory demyelinating polyneuropathy (CIDP)","volume":"36","author":"Mehreen","year":"2023","journal-title":"Pak. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.clineuro.2025.108719_bib93","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/ane.12519","article-title":"Steroids for chronic inflammatory demyelinating polyradiculoneuropathy: evidence base and clinical practice","volume":"133","author":"Press","year":"2016","journal-title":"Acta Neurol. Scand."},{"issue":"1-2","key":"10.1016\/j.clineuro.2025.108719_bib94","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jns.2011.05.035","article-title":"Thromboembolic complications of intravenous immunoglobulin therapy in patients with neuropathy: a two-year study","volume":"308","author":"Rajabally","year":"2011","journal-title":"J. Neurol. Sci."},{"issue":"6","key":"10.1016\/j.clineuro.2025.108719_bib95","doi-asserted-by":"crossref","first-page":"e635","DOI":"10.1212\/WNL.0000000000008742","article-title":"Thromboembolic risk with IVIg: Incidence and risk factors in patients with inflammatory neuropathy","volume":"94","author":"Kapoor","year":"2020","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.clineuro.2025.108719_bib96","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1212\/01.WNL.0000158680.89323.F8","article-title":"Clinical and electrophysiologic correlates of IVIg responsiveness in CIDP","volume":"64","author":"Iijima","year":"2005","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.clineuro.2025.108719_bib97","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/mus.27820","article-title":"Outcome in chronic inflammatory demyelinating polyneuropathy: a systematic review and meta-analysis","volume":"68","author":"Al-Zuhairy","year":"2023","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.clineuro.2025.108719_bib98","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/14737175.2022.2036125","article-title":"Contemporary challenges in the diagnosis and management of chronic inflammatory demyelinating polyneuropathy","volume":"22","author":"Rajabally","year":"2022","journal-title":"Expert Rev. Neurother."},{"issue":"5","key":"10.1016\/j.clineuro.2025.108719_bib99","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2217\/nmt-2017-0017","article-title":"Unconventional treatments for chronic inflammatory demyelinating polyneuropathy","volume":"7","author":"Rajabally","year":"2017","journal-title":"Neurodegener. Dis. Manag."},{"issue":"6","key":"10.1016\/j.clineuro.2025.108719_bib100","first-page":"CD006521","article-title":"Immunotherapy for diabetic amyotrophy","author":"Chan","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/j.clineuro.2025.108719_bib101","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/mus.24554","article-title":"Long-term immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy","volume":"51","author":"Rajabally","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clineuro.2025.108719_bib102","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16073","article-title":"European academy of neurology\/peripheral nerve society guideline on diagnosis and treatment of guillain-barr\u00e9 syndrome","author":"van Doorn","year":"2023","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.clineuro.2025.108719_bib103","article-title":"IgG4-mediated neurologic autoimmunities: understanding the pathogenicity of IgG4, ineffectiveness of IVIg, and long-lasting benefits of anti-B cell therapies","volume":"9","author":"Dalakas","year":"2022","journal-title":"Neurol. (R.) Neuroimmunol. Neuroinflamm."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846725000022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846725000022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:13:21Z","timestamp":1740183201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846725000022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":103,"alternative-id":["S0303846725000022"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2025.108719","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The overlap of diabetic and inflammatory neuropathies: Epidemiology, possible mechanisms, and treatment implications","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2025.108719","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108719"}}